Literature DB >> 18227531

Mechanisms of hepatic steatosis in mice fed a lipogenic methionine choline-deficient diet.

Mary E Rinella1, Marc S Elias, Robin R Smolak, Tao Fu, Jayme Borensztajn, Richard M Green.   

Abstract

The methionine choline-deficient (MCD) diet results in liver injury similar to human nonalcoholic steatohepatitis (NASH). The aims of this study were to define mechanisms of MCD-induced steatosis in insulin-resistant db/db and insulin-sensitive db/m mice. MCD-fed db/db mice developed more hepatic steatosis and retained more insulin resistance than MCD-fed db/m mice. Both subcutaneous and gonadal fat were reduced by MCD feeding: gonadal fat decreased by 23% in db/db mice and by 90% in db/m mice. Weight loss was attenuated in the db/db mice, being only 13% compared with 35% in MCD-fed db/db and db/m mice, respectively. Both strains had upregulation of hepatic fatty acid transport proteins as well as increased hepatic uptake of [14C]oleic acid: 3-fold in db/m mice (P < 0.001) and 2-fold in db/db mice (P < 0.01) after 4 weeks of MCD feeding. In both murine strains, the MCD diet reduced triglyceride secretion and downregulated genes involved in triglyceride synthesis. Therefore, increased fatty acid uptake and decreased VLDL secretion represent two important mechanisms by which the MCD diet promotes intrahepatic lipid accumulation in this model. Feeding the MCD diet to diabetic rodents broadens the applicability of this model for the study of human NASH.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18227531      PMCID: PMC2311450          DOI: 10.1194/jlr.M800042-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  42 in total

Review 1.  Orphan nuclear receptors as eLiXiRs and FiXeRs of sterol metabolism.

Authors:  T T Lu; J J Repa; D J Mangelsdorf
Journal:  J Biol Chem       Date:  2001-07-17       Impact factor: 5.157

Review 2.  SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver.

Authors:  Jay D Horton; Joseph L Goldstein; Michael S Brown
Journal:  J Clin Invest       Date:  2002-05       Impact factor: 14.808

3.  Intracerebroventricular leptin regulates hepatic cholesterol metabolism.

Authors:  Sonya Vanpatten; George B Karkanias; Luciano Rossetti; David E Cohen
Journal:  Biochem J       Date:  2004-04-15       Impact factor: 3.857

4.  Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities.

Authors:  A J Sanyal; C Campbell-Sargent; F Mirshahi; W B Rizzo; M J Contos; R K Sterling; V A Luketic; M L Shiffman; J N Clore
Journal:  Gastroenterology       Date:  2001-04       Impact factor: 22.682

5.  Findings on liver biopsy to investigate abnormal liver function tests in the absence of diagnostic serology.

Authors:  M M Skelly; P D James; S D Ryder
Journal:  J Hepatol       Date:  2001-08       Impact factor: 25.083

6.  Leptin is essential for the hepatic fibrogenic response to chronic liver injury.

Authors:  Isabelle A Leclercq; Geoffrey C Farrell; Rixt Schriemer; Graham R Robertson
Journal:  J Hepatol       Date:  2002-08       Impact factor: 25.083

7.  The methionine-choline deficient dietary model of steatohepatitis does not exhibit insulin resistance.

Authors:  Mary E Rinella; Richard M Green
Journal:  J Hepatol       Date:  2004-01       Impact factor: 25.083

Review 8.  Minireview: adiposity, inflammation, and atherogenesis.

Authors:  Christopher J Lyon; Ronald E Law; Willa A Hsueh
Journal:  Endocrinology       Date:  2003-06       Impact factor: 4.736

9.  Outcomes of liver transplantation for cryptogenic cirrhosis: a single-center study of 71 patients.

Authors:  A Sanjeevi; E Lyden; B Sunderman; R Weseman; R Ashwathnarayan; S Mukherjee
Journal:  Transplant Proc       Date:  2003-12       Impact factor: 1.066

10.  The transport of triglycerides through the secretory pathway of hepatocytes is impaired in apolipoprotein E deficient mice.

Authors:  Arjen R Mensenkamp; Marja J A Van Luyn; Rick Havinga; Bas Teusink; Ian J Waterman; Christopher J Mann; Baukje M Elzinga; Henkjan J Verkade; Victor A Zammit; Louis M Havekes; Carol C Shoulders; Folkert Kuipers
Journal:  J Hepatol       Date:  2004-04       Impact factor: 25.083

View more
  170 in total

1.  Impaired de novo choline synthesis explains why phosphatidylethanolamine N-methyltransferase-deficient mice are protected from diet-induced obesity.

Authors:  René L Jacobs; Yang Zhao; Debby P Y Koonen; Torunn Sletten; Brian Su; Susanne Lingrell; Guoqing Cao; David A Peake; Ming-Shang Kuo; Spencer D Proctor; Brian P Kennedy; Jason R B Dyck; Dennis E Vance
Journal:  J Biol Chem       Date:  2010-05-07       Impact factor: 5.157

2.  Dietary fructose exacerbates hepatocellular injury when incorporated into a methionine-choline-deficient diet.

Authors:  Michael K Pickens; Hisanobu Ogata; Russell K Soon; James P Grenert; Jacquelyn J Maher
Journal:  Liver Int       Date:  2010-06-08       Impact factor: 5.828

3.  Rosiglitazone attenuates age- and diet-associated nonalcoholic steatohepatitis in male low-density lipoprotein receptor knockout mice.

Authors:  Anisha A Gupte; Joey Z Liu; Yuelan Ren; Laurie J Minze; Jessica R Wiles; Alan R Collins; Christopher J Lyon; Domenico Pratico; Milton J Finegold; Stephen T Wong; Paul Webb; John D Baxter; David D Moore; Willa A Hsueh
Journal:  Hepatology       Date:  2010-10-11       Impact factor: 17.425

4.  Dietary supplementation with methyl donors reduces fatty liver and modifies the fatty acid synthase DNA methylation profile in rats fed an obesogenic diet.

Authors:  P Cordero; A M Gomez-Uriz; J Campion; F I Milagro; J A Martinez
Journal:  Genes Nutr       Date:  2012-05-31       Impact factor: 5.523

Review 5.  GC-1: A Thyromimetic With Multiple Therapeutic Applications in Liver Disease.

Authors:  Amedeo Columbano; Grazia Chiellini; Marta Anna Kowalik
Journal:  Gene Expr       Date:  2017-06-13

6.  Current status of therapy in nonalcoholic Fatty liver disease.

Authors:  Scott McNear; Stephen A Harrison
Journal:  Therap Adv Gastroenterol       Date:  2009-01       Impact factor: 4.409

7.  The effect of hepatic ischemia reperfusion injury in a murine model of nonalcoholic steatohepatitis.

Authors:  Amit D Tevar; Callisia N Clarke; Rebecca Schuster; Jiang Wang; Michael J Edwards; Alex B Lentsch
Journal:  J Surg Res       Date:  2011-03-02       Impact factor: 2.192

8.  PKC{delta} is activated in a dietary model of steatohepatitis and regulates endoplasmic reticulum stress and cell death.

Authors:  Michael W Greene; Christine M Burrington; Mary S Ruhoff; Andrew K Johnson; Tepsiri Chongkrairatanakul; Atipon Kangwanpornsiri
Journal:  J Biol Chem       Date:  2010-10-22       Impact factor: 5.157

Review 9.  Regulatable fatty acid transport mechanisms are central to the pathophysiology of obesity, fatty liver, and metabolic syndrome.

Authors:  Paul D Berk
Journal:  Hepatology       Date:  2008-11       Impact factor: 17.425

10.  Dietary sucrose is essential to the development of liver injury in the methionine-choline-deficient model of steatohepatitis.

Authors:  Michael K Pickens; Jim S Yan; Raymond K Ng; Hisanobu Ogata; James P Grenert; Carine Beysen; Scott M Turner; Jacquelyn J Maher
Journal:  J Lipid Res       Date:  2009-03-17       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.